The first developed technology platform with various application scenarios, including infectious disease, fertility, DOA, etc.
50+ kinds of reagents and five high-performance devices, focusing on detecting cardiovascular disease, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and others.
Wondfo optical blood coagulation analyzer is the first one in the world that can test PT, APTT, TT, FIB, and ACT simultaneously.
Our Blood Gas Analyzer BGA-102 can produce the result in 30s. Its advantages of portability, easy operation, durability, and high performance make it ideal for clinics, laboratories, and hospitals.
Wondfo Dry Chemistry Analyzer can test 16 items and provide the result within 2 minutes, ideal for the detection of cardiac markers, kidney function, liver function, pancreatitis, etc.
Ready-to-use lyophilized RT-PCR Reagent;
Gold Standard for COVID-19 Diagnosis
The U-Card Dx™ 2019-nCoV/Flu/RSV Test is an automated, real-time reverse transcriptase polymerase chain reaction (Real time RT-PCR) assay intended for the rapid, in vitro qualitative detection of severe acute respiratory syndrome coronavirus 2 (2019-nCoV), influenza A (Flu A), influenza B (Flu B), and respiratory syncytial virus (RSV) viral RNA from nasopharyngeal (NP) swab or anterior nasal swab specimens. The test is intended as an aid in the diagnosis of coronavirus infection disease (COVID-19) caused by 2019-nCoV and respiratory viral infections caused by Flu A, Flu B or RSV viruses.
Benefits
Short TAT
Rapid result in 38 mins
Room-Temperature Stable
2-30℃
Ready to Use
No sample pre-processing
SPECIFICATION
Description
Catalog No.
WR02
Target Gene
2019-nCoV (N and ORF1ab genes)
Flu A (M gene)
Flu B (NEP gene)
RSV (M gene)